GLP-1s (which stands for glucagon-like peptide-1) are a class of medications that were originally developed to manage type 2 diabetes
0.27 events per 1,000 person-years (HR = 0.89
This level of training allows for more precise evaluation, safer prescribing, and a deeper understanding of how physiology, behavior, and surgical anatomy interact over time
Tuttavia, esistono diverse varianti con propriet e finalit duso specifiche: L'uso di integratori o farmaci a base di carnitina sconsigliato in presenza di determinate condizioni mediche o in associazione con alcuni farmaci, poich potrebbe essere pericoloso
These associations persisted after adjustment for age, sex, body mass index, glycemic control, comorbidities, and screening intensity, suggesting that the observed effect extends beyond weight loss alone
Ensure adequate protein intake to maintain muscle mass and support weight management